These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 12416994)

  • 1. Ellman's-reagent-mediated regeneration of trypanothione in situ: substrate-economical microplate and time-dependent inhibition assays for trypanothione reductase.
    Hamilton CJ; Saravanamuthu A; Eggleston IM; Fairlamb AH
    Biochem J; 2003 Feb; 369(Pt 3):529-37. PubMed ID: 12416994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycothiol disulfide reductase: a continuous assay for slow time-dependent inhibitors.
    Hamilton CJ; Finlay RM; Stewart MJ; Bonner A
    Anal Biochem; 2009 May; 388(1):91-6. PubMed ID: 19233116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutathione reductase turned into trypanothione reductase: structural analysis of an engineered change in substrate specificity.
    Stoll VS; Simpson SJ; Krauth-Siegel RL; Walsh CT; Pai EF
    Biochemistry; 1997 May; 36(21):6437-47. PubMed ID: 9174360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The parasite-specific trypanothione metabolism of trypanosoma and leishmania.
    Krauth-Siegel RL; Meiering SK; Schmidt H
    Biol Chem; 2003 Apr; 384(4):539-49. PubMed ID: 12751784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of substrate analogue inhibitors of trypanothione reductase.
    Duyzend MH; Clark CT; Simmons SL; Johnson WB; Larson AM; Leconte AM; Wills AW; Ginder-Vogel M; Wilhelm AK; Czechowicz JA; Alberg DG
    J Enzyme Inhib Med Chem; 2012 Dec; 27(6):784-94. PubMed ID: 22085139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug target validation of the trypanothione pathway enzymes through metabolic modelling.
    Olin-Sandoval V; González-Chávez Z; Berzunza-Cruz M; Martínez I; Jasso-Chávez R; Becker I; Espinoza B; Moreno-Sánchez R; Saavedra E
    FEBS J; 2012 May; 279(10):1811-33. PubMed ID: 22394478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The synthesis and inhibitory activity of dethiotrypanothione and analogues against trypanothione reductase.
    Czechowicz JA; Wilhelm AK; Spalding MD; Larson AM; Engel LK; Alberg DG
    J Org Chem; 2007 May; 72(10):3689-93. PubMed ID: 17439174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of Trypanosoma cruzi trypanothione reductase in complex with trypanothione, and the structure-based discovery of new natural product inhibitors.
    Bond CS; Zhang Y; Berriman M; Cunningham ML; Fairlamb AH; Hunter WN
    Structure; 1999 Jan; 7(1):81-9. PubMed ID: 10368274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time-dependent inhibitors of trypanothione reductase: analogues of the spermidine alkaloid lunarine and related natural products.
    Hamilton CJ; Saravanamuthu A; Poupat C; Fairlamb AH; Eggleston IM
    Bioorg Med Chem; 2006 Apr; 14(7):2266-78. PubMed ID: 16303308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of nitric oxide with 2-thio-5-nitrobenzoic acid: implications for the determination of free sulfhydryl groups by Ellman's reagent.
    Gergel' D; Cederbaum AI
    Arch Biochem Biophys; 1997 Nov; 347(2):282-8. PubMed ID: 9367537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trypanothione reductase from the human parasite Entamoeba histolytica: a new drug target.
    Tamayo EM; Iturbe A; Hernández E; Hurtado G; de Lourdes Gutiérrez-X M; Rosales JL; Woolery M; Ondarza RN
    Biotechnol Appl Biochem; 2005 Apr; 41(Pt 2):105-15. PubMed ID: 15157186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trypanothione biosynthesis in Leishmania major.
    Oza SL; Shaw MP; Wyllie S; Fairlamb AH
    Mol Biochem Parasitol; 2005 Jan; 139(1):107-16. PubMed ID: 15610825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression, purification, and characterization of Leishmania donovani trypanothione reductase in Escherichia coli.
    Mittal MK; Misra S; Owais M; Goyal N
    Protein Expr Purif; 2005 Apr; 40(2):279-86. PubMed ID: 15766869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of substrate analogues for trypanothione reductase.
    el-Waer AF; Benson T; Douglas KT
    Int J Pept Protein Res; 1993 Feb; 41(2):141-6. PubMed ID: 8458687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific peptide inhibitors of trypanothione reductase with backbone structures unrelated to that of substrate: potential rational drug design lead frameworks.
    McKie JH; Garforth J; Jaouhari R; Chan C; Yin H; Besheya T; Fairlamb AH; Douglas KT
    Amino Acids; 2001; 20(2):145-53. PubMed ID: 11332449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationally designed selective inhibitors of trypanothione reductase. Phenothiazines and related tricyclics as lead structures.
    Benson TJ; McKie JH; Garforth J; Borges A; Fairlamb AH; Douglas KT
    Biochem J; 1992 Aug; 286 ( Pt 1)(Pt 1):9-11. PubMed ID: 1355650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular docking of a series of peptidomimetics in the trypanothione binding site of T. cruzi trypanothione reductase.
    da Rocha Pita SS; Cirino JJ; de Alencastro RB; Castro HC; Rodrigues CR; Albuquerque MG
    J Mol Graph Model; 2009 Nov; 28(4):330-5. PubMed ID: 19766515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and biological evaluation of new potent 5-nitrofuryl derivatives as anti-Trypanosoma cruzi agents. Studies of trypanothione binding site of trypanothione reductase as target for rational design.
    Aguirre G; Cabrera E; Cerecetto H; Di Maio R; González M; Seoane G; Duffaut A; Denicola A; Gil MJ; Martínez-Merino V
    Eur J Med Chem; 2004 May; 39(5):421-31. PubMed ID: 15110968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trypanothione efficiently intercepts nitric oxide as a harmless iron complex in trypanosomatid parasites.
    Bocedi A; Dawood KF; Fabrini R; Federici G; Gradoni L; Pedersen JZ; Ricci G
    FASEB J; 2010 Apr; 24(4):1035-42. PubMed ID: 19952282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural insights into the enzymes of the trypanothione pathway: targets for antileishmaniasis drugs.
    Colotti G; Baiocco P; Fiorillo A; Boffi A; Poser E; Chiaro FD; Ilari A
    Future Med Chem; 2013 Oct; 5(15):1861-75. PubMed ID: 24144416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.